Ardelyx Inc (ARDX)
5.115
+0.20
(+3.96%)
USD |
NASDAQ |
Nov 21, 16:00
5.12
0.00 (0.00%)
After-Hours: 20:00
Ardelyx Gross Profit Margin (Quarterly): 83.99% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 83.99% |
| June 30, 2024 | 87.11% |
| March 31, 2024 | 84.51% |
| December 31, 2023 | 85.23% |
| September 30, 2023 | 86.36% |
| June 30, 2023 | 84.38% |
| March 31, 2023 | 86.48% |
| December 31, 2022 | 92.84% |
| September 30, 2022 | 85.32% |
| June 30, 2022 | 94.54% |
| March 31, 2022 | 81.84% |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 |
| Date | Value |
|---|---|
| March 31, 2021 | 84.81% |
| December 31, 2020 | 99.78% |
| September 30, 2020 | |
| June 30, 2020 | 92.32% |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | 80.09% |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | 98.84% |
| June 30, 2018 | |
| March 31, 2018 | 80.00% |
| December 31, 2017 | 80.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
81.84%
Minimum
Mar 2022
99.78%
Maximum
Dec 2020
87.82%
Average
85.84%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Verve Therapeutics Inc | -- |
| United Therapeutics Corp | 88.90% |
| Zoetis Inc | 70.64% |
| NovaBay Pharmaceuticals Inc | 65.26% |
| Palatin Technologies Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -44.58% |
| Return on Assets | -22.12% |
| Return on Invested Capital | -30.45% |
| Profit Margin (Quarterly) | -0.82% |
| Operating Margin (Quarterly) | 2.27% |
| Return on Net Operating Assets | -99.60% |